αααααβααΎαNEO β’ NASDAQ
add
NeoGenomics, Inc.
6.40$
ααΆαβαααβααΌαβαα»αβααΈααααΆαα(0.70%)-0.045
6.35$
ααΆααα·αα 1 α§αααΆ, 12:30:53 AM ααααβααα -4 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
6.58$
α
αααααααααααα
6.08$ - 6.50$
α
ααααααα½αααααΆαα
α»αααααα
6.08$ - 19.11$
ααΎαβαα»αβααΈααααΆα
822.76Β ααΆα USD
ααα ααα½αααΌαααααα
2.10Β ααΆα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 172.00Β ααΆα | 10.57% |
α
αααΆαααααα·ααααα·ααΆα | 93.15Β ααΆα | 9.92% |
α
αααΌααα»ααα | -15.32Β ααΆα | -6.97% |
ααααΆααα
αααααα»ααα | -8.91 | 3.26% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.04 | 33.33% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 2.29Β ααΆα | 90.44% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 4.99% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 386.84Β ααΆα | -6.83% |
ααααααααα»α | 1.64Β αααΈααΆα | -2.57% |
ααΆαααα½ααα»αααααΌαααα»α | 735.70Β ααΆα | -0.54% |
ααΌαβααααα»α | 902.34Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 128.46Β ααΆα | β |
ααααααααααΉαααααα
| 0.93 | β |
ααα
ααααααΎαααααα | -2.42% | β |
ααα
ααααααΎααΎααα»α | -2.63% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(USD) | ααααΌ 2024info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | -15.32Β ααΆα | -6.97% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 9.80Β ααΆα | -44.89% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -5.47Β ααΆα | -131.79% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 687.00Β ααΆαα | -45.91% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 5.02Β ααΆα | -86.15% |
ααα αΌαααΆα
αααααΆααααααα | 2.87Β ααΆα | -80.09% |
α’αααΈ
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
ααΆααααααΎαα‘αΎα
2002
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
2,200